We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Intermittent Cold Blood vs Crystalloid Cardioplegia in Aortic Valve Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00257777
Recruitment Status : Completed
First Posted : November 23, 2005
Last Update Posted : July 6, 2011
Information provided by:

Study Description
Brief Summary:
Controversies still exists concerning the overall clinical effects of blood-based vs. crystalloid- based cardioplegic solution for myocardial protection during cardiac arrest. Both techniques are used world-wide. No larger prospectively randomized studies comparing the two methods have been reported. The aim of this study is to collect a large number of clinical data to create a proper basis for evaluation of the two techniques.

Condition or disease Intervention/treatment
Aortic Valve Disease Coronary Artery Disease Procedure: Myocardial protection techniques

Detailed Description:
All patients admitted for aortic valve replacement with or without concomitant CABG and operated by E.Ø. or G.T. are included in the study. All preoperative, operative and postoperative data are prospectively recorded, focusing on clinical outcome parameters

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 350 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Intermittent Cold Blood vs Crystalloid Cardioplegia in Aortic Valve Surgery
Study Start Date : November 2003
Primary Completion Date : November 2007
Study Completion Date : November 2007
Arms and Interventions

Outcome Measures

Primary Outcome Measures :
  1. Myocardial function,
  2. postoperative ventilatory support, postoperative arrhythmia,
  3. blood transfusions,
  4. physical recovery,
  5. mortality.

Secondary Outcome Measures :
  1. Costs

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Aortic valve replacement
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00257777

Oslo, Norway, 0027
Sponsors and Collaborators
Oslo University Hospital
Principal Investigator: Eivind Øvrum, MD,PhD Oslo University Hospital
More Information

ClinicalTrials.gov Identifier: NCT00257777     History of Changes
Other Study ID Numbers: AVR03
First Posted: November 23, 2005    Key Record Dates
Last Update Posted: July 6, 2011
Last Verified: November 2005

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases